DOCSLIB.ORG

Merck Corporate Responsibility Report 2018

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Merck Corporate Responsibility Report 2018 CORPORATE RESPONSIBILITY Report 2018 Merck Corporate Responsibility Report 2018 Content 5 STRATEGY & MANAGEMENT 84 EMPLOYEES 6 Company profile 85 Attractive employer 9 CR strategy 90 Diversity 11 Stakeholder dialogue 94 Health and safety 14 Materiality analysis 97 Employee engagement 99 Good leadership 20 BUSINESS ETHICS 21 Corporate Governance 101 ENVIRONMENT 21 Governance 102 Environmental stewardship 22 Compliance 105 Climate action 27 Responsible marketing 108 Waste and recycling 29 Interactions with health systems 110 Water management 31 Suppliers 113 Plant and process safety 31 Supply chain standards 115 Biodiversity 34 Mica supply chain 36 Human rights 38 Bioethics 116 COMMUNITY 41 Clinical studies 117 Community involvement 45 Animal welfare 119 Global Health 121 Broad Minds 48 PRODUCTS 49 Innovation and digitalization 124 FACTS & FIGURES 53 Sustainable products 125 Report profile 53 Sustainable product design 127 Indicators 56 Packaging and recycling 127 Economics 58 Health for all 128 Business ethics 58 Global strategy 131 Employees 61 Focus programs 144 Environment 64 Open innovation sharing 150 Community 66 Pharmaceutical supply chain 152 Goals 68 Prices of medicines 164 Recognition and rankings 70 Health awareness 167 Sustainable Development Goals 73 Product safety and quality 172 Non-financial report 73 Chemical product safety 179 GRI content index 76 Patient safety 179 General disclosures 79 Product-related crime 184 Economic Standards 82 Transport and warehouse safety 187 Environmental Standards 190 Social Standards 197 Global Compact CoP 201 Assurance report 2 Merck Corporate Responsibility Report 2018 Letter from the CEO Ladies and gentlemen, friends of Merck, In 2018 we ran an employee campaign called “350 We aspire to be a leading science and technology company, Good Deeds”. The name says it all – to commemorate our which also means developing technological advances that 350th anniversary, we rolled up our sleeves to support good benefit all humankind. This ranges from treatments for causes across 60 countries. We made donations to chari- serious diseases, to products and services that make table initiatives, launched new projects and volunteered our research and biomanufacturing faster and more reliable, time. Our employees poured great effort into helping people through to materials for the technologies of tomorrow. We with disabilities; they renovated hospitals and cooked meals are leveraging the great potential presented by genome with disadvantaged children. Starting this year, our work- editing, big data and artificial intelligence while living up force across the globe will be permitted to take up to two to the massive responsibility that arises from utilizing such days of paid leave per year to volunteer for charitable activ- technologies. To keep our moral compass aligned, we ities spearheaded or supported by Merck. discuss complex ethical issues in our Bioethics Advisory While I am proud to be part of a company that is so Panel, consisting of internal and external experts from a deeply dedicated to community outreach, corporate respon- variety of fields and cultures, and comply with the clear-cut sibility means so much more to us. Indeed, our entire recommendations they make. business model is founded on this sense of responsibility. 3 Merck Corporate Responsibility Report 2018 Last but not least, responsible conduct involves respecting Sustainable Solutions covers everything that we at the interests of our employees, customers and investors. In the company do to ensure that our processes, products and line with this ethos, we are deeply committed to the United services contribute to sustainability, specifically in terms of Nations Global Compact and its principles on human rights, climate and environment. Thanks to our liquid crystals, for labor standards, environmental protection, and anti-corrup- instance, energy-efficient smart windows can block sunlight tion. and help reduce the energy needed for air conditioning by In 2018 we realigned our corporate responsibility up to 40%. Another example is Design for Sustainability, a strategy to reflect a shared value approach that centers system our Life Science team uses to analyze and enhance more heavily on creating long-lasting added value for both products at the development stage in a bid to conserve our company and society. We also narrowed the focus of our resources from cradle to grave. three strategic spheres of activity. Broad Minds embodies our tradition of promoting STEM Under Global Health, we partner with other actors education, scientific research and culture. We are on a quest to support a variety of initiatives that improve access to to spark enthusiasm for science among the next genera- health services particularly for people in low- and middle- tion. In 2018, we were therefore thrilled to host the German income countries. Our non-profit Merck Foundation is like- national “Jugend forscht” young researchers competition wise focused on achieving this goal. For me personally, the for the third time. As someone who lives and breathes greatest proof that we are on the right track is our fourth- research, I thoroughly enjoyed interacting with so many place ranking in the Access to Medicine Index, where we curious, talented up-and-coming scientists and discussing beat out some of the giants in the pharmaceutical industry. their ideas and projects. It is also reflected in our advances in malaria and antimi- We at Merck absolutely believe that progress thrives on crobial research, our continued fight against the tropical the nourishment of creative minds. The wide-ranging exam- disease schistosomiasis, and our many awareness ples contained in this report illustrate that we do more than campaigns such as “Embracing Carers”. pay mere lip service to responsibility – we live it every day. For us, scientific research and responsible entrepreneur- ship go hand in hand, a principle that will guide us today, tomorrow and beyond. Yours, Stefan Oschmann Chairman of the Executive Board and CEO 4 Merck Corporate Responsibility Report 2018 Strategy & Management Strategy & Management Within this chapter: 6 Company profile 11 Stakeholder dialogue 9 CR strategy 14 Materiality analysis 5 Merck Corporate Responsibility Report 2018 Strategy & Management Company profile Part of the non-financial report We are Merck, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. Our work makes a positive difference in millions of people’s lives every day. In line with our strategic direction, in Healthcare, we discover unique ways to treat the most challenging diseases such as multiple sclerosis and cancer. Our Life Science experts empower scientists by developing tools and solutions that help deliver breakthroughs more quickly. And in Performance Materials, we develop science that sits inside technologies and changes the way we access and display information. Everything we do is fueled by a belief in science and tech- and as EMD Performance Materials in the high-tech mate- nology as a force for good. A belief that has driven our work rials business. since 1668 and will continue to inspire us to find more joyful Apart from our three business sectors, our financial and sustainable ways to live. We are curious minds dedi- reporting presents the five regions Europe, North America, cated to human progress. Asia-Pacific (APAC), Latin America as well as Middle East and Africa (MEA). As of December 31, 2018, we had 51,749 We are Merck employees worldwide, which compares with 52,941 on We hold the global rights to the Merck name and brand. The December 31, 2017. only exceptions are Canada and the United States. In these In 2018, our 207 subsidiaries with employees in 66 countries, we operate as EMD Serono in the biopharmaceu- countries generated sales of € 14.8 billion. Our 90 produc- tical business, as MilliporeSigma in the life science business tion sites are located across 21 countries. Employees and sales by region – 2018 Group structure infertility, growth disorders as well as certain cardiovascular Merck comprises three business sectors: Healthcare, Life and metabolic diseases. Biopharma is the larger of our Science, and Performance Materials. Our Healthcare busi- Healthcare businesses and operates in four franchises: ness sector – the biggest among our three business sectors Oncology, Neurology & Immunology, Fertility and General – comprises the two businesses Biopharma and Aller- Medicine & Endocrinology. Our R&D pipeline positions us gopharma. On December 1, our Consumer Health business with a clear focus on becoming a global specialty innovator transferred to Procter & Gamble (P&G). in oncology, immuno-oncology and immunology including Our Biopharma business discovers, develops, manufac- MS. Our allergy business Allergopharma is one of the tures and markets innovative pharmaceutical and biological leading companies in the field of allergy immunotherapy prescription drugs to treat cancer, multiple sclerosis (MS), (AIT) in Europe. For high-precision, effective allergy 6 Merck Corporate Responsibility Report 2018 Strategy & Management therapy, we offer comprehensive diagnosis solutions as a BrightLab™, our digital ecosystem for complete lab basis for individual treatment concepts. Our AIT products management. concentrate on causal treatment of type 1 allergies such as Our Performance Materials business sector comprises allergic rhinitis (for example, hay fever) and allergic
Load more

Recommended publications
  • Champion Brands to My Wife, Mercy the ‘Made in Germany’ Champion Brands Nation Branding, Innovation and World Export Leadership
    The ‘Made in Germany’ Champion Brands To my wife, Mercy The ‘Made in Germany’ Champion Brands Nation Branding, Innovation and World Export Leadership UGESH A. JOSEPH First published 2013 by Gower Publishing Published 2016 by Routledge 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN 711 Third Avenue, New York, NY 10017, USA Routledge is an imprint of the Taylor & Francis Group, an informa business Copyright © Ugesh A. Joseph 2013 Ugesh A. Joseph has asserted his right under the Copyright, Designs and Patents Act, 1988, to be identified as the author of this work. Gower Applied Business Research Our programme provides leaders, practitioners, scholars and researchers with thought provoking, cutting edge books that combine conceptual insights, interdisciplinary rigour and practical relevance in key areas of business and management. All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library. The Library of Congress has cataloged the printed edition as follows: Joseph, Ugesh A. The ‘Made in Germany’ champion brands: nation branding, innovation and world export leadership / by Ugesh A. Joseph. pages cm Includes bibliographical references and index. ISBN 978-1-4094-6646-8 (hardback: alk.
    [Show full text]
  • Merck Annual Report 2009
    More information inside the cover: Business development 2000 – 2009 Merck CONTENTS Annual Report 2009 Publication contributors Published on February 23, 2010 by Merck KGaA, Corporate Communications Frankfurter Strasse 250, 64293 Darmstadt, Germany Tel.: +49 (0) 6151-72 0, fax: +49 (0) 6151-72 5577 E-mail: [email protected] Website: www.merck.de Concept, design and typesetting: XEO GmbH, Düsseldorf, Germany Annual Report 2009 Photographs: Pages 6, 10 and 11: Catrin Moritz, Essen; Pages 1, 2, 4, 35, 51, 57, and 63: Reinhard Koslowski, Düsseldorf Printing: Franz Kuthal GmbH & Co. KG, Mainaschaff, Germany Paper: FSC-certified “heaven 42” by Scheufelen W 840 539 350210 www.merck.de Contents Contents COMPANY BUSINESS DEVELOPMENT 2000 – 2009 2 The history of Merck This overview may include historically adjusted values in order to ensure comparability with 2009. 3 Becoming a global, publicly listed company 4 Merck today 4 The future Change vs. 2008 € million 2000 2001 2002 2003 2004 2005 20061 20071 2008 2009 in % Total revenues 2 6,910 7,721 7,521 7,364 6,017 5,887 4,485 7,081 7,590 7,747 2.1 TO OUR SHAREHOLDERS Pharmaceuticals 3,047 3,484 3,265 3,458 3,601 3,905 2,338 4,900 5,456 5,812 6.5 6 Letter from Karl-Ludwig Kley Merck Serono 1,941 2,228 1,850 1,546 1,619 1,817 1,938 4,480 5,014 5,345 6.6 10 Executive Board Generics 3 790 936 1,096 1,585 1,625 1,712 – – – – – Consumer Health Care 299 320 319 327 357 376 400 420 442 467 5.7 3 MANAGEMENT REPORT Imaging 17 – – – – – – – – – – Chemicals 1,679 1,729 1,791 1,707 1,696 1,906 2,113 2,152 2,127
    [Show full text]
  • Merck Serono the Biopharma Division of Merck
    Merck Serono The Biopharma Division of Merck September 16, 2014 Merck Our aspiration is to make great things happen Merck is the oldest pharmaceutical and chemical company in the world founded in 1668 in Darmstadt, Germany Merck is a publicly listed company on the DAX at the Frankfurt Stock exchange. The Merck family holds 70% of the shares Total Revenues : €11 billion in 2013 EBITDA Pre : €3.25 billion Around 38,000 employees in 66 countries 2 Our History Merck was founded by Friedrich Jacob Merck (1621-1678) when he acquired the Angel Pharmacy (Engel-Apotheke) in 1668 Heinrich Emanuel Merck (1794–1855) begins production on an industrial scale Merck and the US pharmaceutical company Merck, Sharp & Dohme have been two independent companies since 1917. Today, we are Merck worldwide (except for Canada and the US where we are known as EMD). 3 Our Corporate Structure Merck Group Merck Consumer Performance Merck Serono Health Materials Millipore • Oncology • Everyday health • Liquid Crystals • BioScience • ImmunoOncology protection • Pigments • Lab Solutions • Immunology/NDD • Women‘s and & Cosmetics • Process Solutions • Fertility children‘s health • Endocrinology & • Cough and cold General Medicine Biosimilars Allergopharma Pharma Business Merck Serono at a Glance We operate under the Group: Largest division of Merck name EMD Serono in Established: January 5, 2007 North America Business: Biopharmaceuticals Employees: ~15,000 Total Revenues: €6.3 billion in 2013 Headquarters: Darmstadt, Germany Global reach: Products commercialized in 150
    [Show full text]
  • Acta Archive Indexes Directory
    VOLUME 50, NO. 1 | 2017 ALDRICHIMICA ACTA Acta Archive Indexes • Chronological • Affiliations 4-Substituted Prolines: Useful Reagents in Enantioselective HIMICA IC R A Synthesis and Conformational Restraints in the Design of D C L T Bioactive Peptidomimetics A A • Authors • Painting Clues Recent Advances in Alkene Metathesis for Natural Product Synthesis—Striking Achievements Resulting from Increased 1 7 9 1 Sophistication in Catalyst Design and Synthesis Strategy 68 20 • Titles The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. Chronological YEAR Vol. No. Authors Title Affiliation 1968 1 1 Buth, William F. Fragment Information Retrieval of Structures Aldrich Chemical Co., Inc. 1 Bader, Alfred Chemistry and Art Aldrich Chemical Co., Inc. 1 Higbee, W. Edward A Portrait of Aldrich Chemical Company Aldrich Chemical Co., Inc. 2 West, Robert Squaric Acid and the Aromatic Oxocarbons University of Wisconsin at Madison 2 Bader, Alfred Of Things to Come Aldrich Chemical Co., Inc. 3 Koppel, Henry The Compleat Chemists Aldrich Chemical Co., Inc. 3 Biel, John H. Biogenic Amines and the Emotional State Aldrich Chemical Co., Inc. 4 Biel, John H. Chemistry of the Quinuclidines Aldrich Chemical Co., Inc. Warawa, E.J. 4 Clark, Anthony M. Dutch Art and the Aldrich Collection Aldrich Chemical Co., Inc. 1969 2 1 May, Everette L. The Evolution of Totally Synthetic, Strong Analgesics National Institutes of Health 1 Anonymous Computer Aids Search for R&D Chemicals Reprinted from C&EN 1968, 46 (Sept. 2), 26-27 2 Hopps, Harvey B. The Wittig Reaction Aldrich Chemical Co., Inc. Biel, John H.
    [Show full text]
  • MERCK Kgaa DARMSTADT, GERMANY
    MERCK KGaA DARMSTADT, GERMANY Annual Financial Statements 2016 DISCLAIMER Publication of Merck KGaA, Darmstadt, Germany. In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany, operate as EMD Serono in Healthcare, MilliporeSig- ma in Life Science and EMD Performance Materials. To reflect such fact and to avoid any misconception of the reader of the publication certain logos, terms and names of businesses of the publication have been substituted or additional descriptions have been added. This version of the publication, therefore, slightly deviates from the otherwise identical version of the publication provided outside the United States and Canada. For nearly 350 years, curious people at our company have been bringing ideas to life. As a global science and technology company, a passion for research and discovery is our most valuable resource. With our three business sectors, namely Healthcare, Life Science and Performance Materials, we improve the quality of life of patients, in- crease the success of our customers, and offer solutions for diverse challenges. Curiosity is and remains our strongest driving force for future-oriented innovations. Annual Financial Statements 3 Combined Management Annual Financial Statements Report 112 – 158 03 – 110 112 Balance Sheet as of December 31, 2016 113 Income Statement from the period 003 Fundamental Information about the Group from January 1 to December 31, 2016 003 The Group 114 Notes to the Annual Financial Statements 010 Objectives and strategies 115 Notes to the Balance Sheet 016 Internal Management System 125 Notes to the Income Statement 020 Corporate Responsibility 129 Other Disclosures 028 Research and development 132 Members of the Executive Board of Merck KGaA, 040 People Darmstadt, Germany 133 Supervisory Board 046 Report on Economic Position 134 Disclosures in accordance with section 160 (1) no.
    [Show full text]
  • Merck Serono Constantly Seeks: • Novel Therapeutic Agents and Drug Targets in Our Key Therapeutic Areas
    PharmaForum 2010, am 2. November in Mainz 1. Company Merck is the world’s oldest pharmaceutical and chemical company with approximately 40.000 employers in 64 countries. Its roots date back to 1668, when Friedrich Jacob Merck purchased the "Angel Pharmacy" in Darmstadt – still owned by the Merck family today. Around 30% of the company’s total capital is publicly traded, while the Merck family owns an interest of about 70% via the general partner E. Merck KG. Merck shares have been included in the DAX ® 30 since 2007. In early 2007, the acquisition of the Swiss firm Serono, Europe’s leading biopharmaceutical company, was completed. The scope of this strategically compelling combination is expected to raise Merck’s competitiveness in the global pharmaceutical market. Analogical, Merck strengthened its chemical sector with the acquisition of Millipore in 2010. 2. Core Competences 2.1 Pharmaceuticals Merck discovers, develops, manufactures and markets innovative prescription drugs as well as over-the-counter products. Merck develop therapies for high unmet medical needs. Through their targeted effect, these help patients to live a longer and better life. Our over-the-counter products can prevent disease and relieve minor complaints. Key therapeutic areas and products ⇒ Oncology: Erbitux® (metastatic colorectal cancer, head and neck cancer), UFT® (colorectal cancer) ⇒ Neurodegenerative Diseases: Rebif® (multiple sclerosis) ⇒ Fertility: Gonal-f®, Ovitrelle®, Pergoveris™, Luveris®, Crinone®, Cetrotide® ⇒ Endocrinology: Saizen® (growth hormone disorders), Serostim® (HIV- associated wasting), Kuvan® (phenylketonuria) ⇒ CardioMetabolic Care: Glucophage® family (type 2 diabetes), Concor® family (cardiovascular diseases), Euthyrox® (thyroid diseases) ⇒ Other therapeutic areas: Cyanokit® (cyanide poisoning) and other products Seite 2 2.2 Chemicals With a range of more than 40.000 products, Merck Millipore ranks third in the life science market.
    [Show full text]